Cover C, Mansouri A, Knight TR, Bajt ML, Lemasters JJ, Pessayre D, et al
Not too concentrated, not too dilute, with enough peptide for a meaningful protocol run
This protocol isn't appropriate for patients who are pregnant or nursing, individuals under 18, those with active cancer, or patients with contraindications to GLP-1 medications (medullary thyroid carcinoma history, MEN2 syndrome, history of pancreatitis)
While it is categorized as a key miRNA influencing PTGS2, specific studies detailing whether it upregulates or downregulates PTGS2 have not been thoroughly investigated
Liu-Smith, R
The initial B12 IV drip can take up to 30 minutes and can be administered weekly